This webinar is designed to describe the underlying concept and controversies around the definition of immune tolerance, to inform their clinical care and education and to be able to apply the concepts presented to clinical monitoring, therapeutic decision and patient education and outreach. This is also intended to promote further open dialogue among international hepatology community regarding mechanisms and significance of apparent immune tolerance in HBV-infected patients and to identify ways to collaborate and fund ways to work in this field.